Table 1 shows the prevalence and standard errors of 12-month and lifetime DSM-5 cannabis use disorder for the entire sample and by sociodemographic characteristics. (In addition, Figure 1 summarizes 12-month prevalence for the entire sample and by sex and age). As shown in Table 1, the prevalence of 12-month and lifetime DSM-5 cannabis use disorder was 2.54% and 6.27%. The 12-month and lifetime prevalence of mild, moderate and severe cannabis use disorders was 1.38%, 0.59% and 0.57%; and 2.85%, 1.42% and 2.00%, respectively.
